EP 1354043 A2 20031022 - SEQUENCES INVOLVED IN PHENOMENA OF TUMOUR SUPPRESSION, TUMOUR REVERSION, APOPTOSIS AND/OR VIRUS RESISTANCE AND THEIR USE AS MEDICINES
Title (en)
SEQUENCES INVOLVED IN PHENOMENA OF TUMOUR SUPPRESSION, TUMOUR REVERSION, APOPTOSIS AND/OR VIRUS RESISTANCE AND THEIR USE AS MEDICINES
Title (de)
SEQUENZEN HINEINGEZOHEN IN TUMORSUPPRSSIONS-, TUMORREVERSIONS- , APOPTOSE- UND/ODER VIRUSRESISTENZPHENOMENEN , UND DEREN ANWENDUNG ALS ARZNEIMITTEL
Title (fr)
SEQUENCES IMPLIQUEES DANS LES PHENOMENES DE SUPPRESSION TUMORALE, REVERSION TUMORALE, APOPTOSE ET/OU RESISTANCE AUX VIRUS ET LEUR UTILISATION COMME MEDICAMENTS
Publication
Application
Priority
- FR 0200273 W 20020123
- FR 0100899 A 20010123
Abstract (en)
[origin: FR2819824A1] The invention concerns in particular novel sequences involved in molecular pathways of tumour suppression, tumour reversion, apoptosis and/or virus resistance. The invention also concerns the use of said sequences or treatment against cancer, viral diseases, neurodegenerative diseases, as well as in diagnosis and for implementing screening methods for compounds to be tested. The invention further concerns methods for detection and/or assay of the inventive sequences or of their expression products in a biological sample.
IPC 1-7
C12N 15/12; C12N 15/11; C12N 15/86; C07K 14/47; C07K 16/18; A01K 67/027; C12Q 1/68; A61K 38/17; A61K 39/395; A61K 48/00; G01N 33/68
IPC 8 full level
A01K 67/027 (2006.01); A61K 35/12 (2015.01); A61K 35/76 (2015.01); A61K 38/00 (2006.01); A61K 38/16 (2006.01); A61K 39/395 (2006.01); A61K 48/00 (2006.01); A61P 25/00 (2006.01); A61P 31/12 (2006.01); A61P 35/00 (2006.01); C07K 14/47 (2006.01); C07K 16/18 (2006.01); C07K 19/00 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12N 15/12 (2006.01); C12P 21/02 (2006.01); C12Q 1/02 (2006.01); C12Q 1/68 (2006.01); G01N 33/15 (2006.01); G01N 33/50 (2006.01); G01N 33/53 (2006.01); G01N 33/566 (2006.01); G01N 33/569 (2006.01); A61K 39/00 (2006.01)
CPC (source: EP US)
A61P 25/00 (2018.01 - EP); A61P 31/12 (2018.01 - EP); A61P 35/00 (2018.01 - EP); C07K 14/4702 (2013.01 - EP US); C07K 14/4747 (2013.01 - EP US); A01K 2217/05 (2013.01 - EP US); A61K 38/00 (2013.01 - EP US); A61K 39/00 (2013.01 - EP US); A61K 48/00 (2013.01 - EP US); C12N 2799/021 (2013.01 - EP US)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
FR 2819824 A1 20020726; CA 2435776 A1 20020801; EP 1354043 A2 20031022; JP 2004537268 A 20041216; US 2004241671 A1 20041202; WO 02059256 A2 20020801; WO 02059256 A3 20030403
DOCDB simple family (application)
FR 0100899 A 20010123; CA 2435776 A 20020123; EP 02701321 A 20020123; FR 0200273 W 20020123; JP 2002559543 A 20020123; US 46689404 A 20040414